# Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
Canonical URL: https://biopharmsignal.com/news/ALGS/aligos-therapeutics-to-announce-1st-quarter-2026-financial-results-on-may-7-2026
Ticker: ALGS
Company: Aligos Therapeutics
Source: Aligos Therapeutics
Published: 2026-04-30 20:05 EST
Original Source URL: https://investor.aligos.com
## Summary

SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the Company’s

## Article Body
SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the Company’s
## Recent Company News
- 2026-05-27 06:30 EST — [Aligos Therapeutics Presents Positive Data at the EASL Congress 2026](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-presents-positive-data-at-the-easl-congress-2026) — Source: Aligos Therapeutics
- 2026-05-13 06:05 EST — [Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-announces-ten-abstracts-accepted-for-presentation-at-the-easl-congress-2026) — Source: Aligos Therapeutics
- 2026-05-07 20:06 EST — [Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-reports-recent-business-progress-and-first-quarter-2026-financial-results) — Source: Aligos Therapeutics
- 2026-04-30 20:05 EST — [Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-to-announce-1st-quarter-2026-financial-results-on-may-7-2026) — Source: Aligos Therapeutics
- 2026-04-24 12:00 EST — [Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ALGS/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Aligos Therapeutics
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)